Publication Highlight: Activation of the IKK2/NF-κB pathway in VSMCs inhibits calcified vascular stiffness in Chronic Kidney Disease
Publication Highlight: Activation of the IKK2/NF-κB pathway in VSMCs inhibits calcified vascular stiffness
European Molecular Imaging Meeting 2026
Visit Scintica at EMIM 2026 — Booth #202
We’re excited to share that Scintica will be exhibiting at EMIM 2026, happening March 24–27 at the Cankarjev Dom Congress Centre in Ljubljana, Slovenia.
EMIM is one of the leading meetings in the molecular imaging community, bringing together scientists and industry partners to explore new developments in morphological, functional, and molecular imaging.
Visit us at Booth 202 to learn more about our preclinical imaging and research solutions. Our team will be there to answer questions, demonstrate technologies, and discuss how our systems can support your work.
We look forward to seeing you in Ljubljana!
Location: Cankarjev Dom Congress Centre, Ljubljana, Slovenia
Dates: March 24–27, 2026
Booth: 202
Read more about Science!
Application Note: Bioprinting 3D Multi-cellular Cartilage Spheroids Using Laser-Assisted Technology
Application Note: Bioprinting 3D Multi-cellular Cartilage Spheroids Using Laser-Assisted Technology View Paper Here
Publication Highlight: Single High-Dose Erythropoietin Disrupts Bone Homeostasis via Osteoclastogenic Pathways
Publication Highlight: Single High-Dose Erythropoietin Disrupts Bone Homeostasis via Osteoclastogenic Pathways View Paper
Publication Highlight: Long-Term Optical Imaging Reveals Bone Marrow Clearance and Extramedullary Escape in BCMA CAR-NK Therapy
Publication Highlight: Long-Term Optical Imaging Reveals Bone Marrow Clearance and Extramedullary Escape in
Publication Highlight: Overexpression of IL-32γ inhibits skin cancer formation through suppression of NF-κB and its downstream factors
Publication Highlight: Overexpression of IL-32γ inhibits skin cancer formation through suppression of NF-κB
Publication Highlight: The role of phosphodiesterase 5 inhibitors in attenuating obesity-induced metabolic disorders
Publication Highlight: The role of phosphodiesterase 5 inhibitors in attenuating obesity-induced metabolic disorders